Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Neoplasms | 13 | 2023 | 4320 | 0.590 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 13 | 2021 | 1661 | 0.490 |
Why?
|
| Carcinoma, Hepatocellular | 8 | 2023 | 2298 | 0.470 |
Why?
|
| Respiration | 8 | 2013 | 1657 | 0.400 |
Why?
|
| Radiotherapy Dosage | 15 | 2023 | 2898 | 0.360 |
Why?
|
| Cholangiocarcinoma | 4 | 2018 | 552 | 0.350 |
Why?
|
| Movement | 9 | 2010 | 1478 | 0.350 |
Why?
|
| Radiotherapy, Intensity-Modulated | 6 | 2021 | 801 | 0.340 |
Why?
|
| Bile Duct Neoplasms | 3 | 2015 | 605 | 0.250 |
Why?
|
| Radiosurgery | 3 | 2019 | 1342 | 0.230 |
Why?
|
| Radiotherapy, Conformal | 4 | 2009 | 548 | 0.200 |
Why?
|
| Lymphopenia | 1 | 2022 | 281 | 0.170 |
Why?
|
| Lymphatic Irradiation | 3 | 2009 | 115 | 0.160 |
Why?
|
| Bilirubin | 1 | 2020 | 436 | 0.150 |
Why?
|
| Tumor Burden | 5 | 2017 | 1893 | 0.150 |
Why?
|
| Lymph Nodes | 3 | 2019 | 3466 | 0.140 |
Why?
|
| Serum Albumin | 1 | 2020 | 672 | 0.140 |
Why?
|
| Cholecystitis | 1 | 2017 | 180 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2015 | 20570 | 0.130 |
Why?
|
| Models, Statistical | 3 | 2020 | 5079 | 0.130 |
Why?
|
| Gallbladder | 1 | 2017 | 308 | 0.120 |
Why?
|
| Respiratory Mechanics | 2 | 2010 | 699 | 0.110 |
Why?
|
| Photons | 1 | 2018 | 589 | 0.110 |
Why?
|
| Radiotherapy | 2 | 2014 | 1499 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2018 | 9280 | 0.090 |
Why?
|
| Radiation Injuries | 2 | 2017 | 1189 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 1096 | 0.090 |
Why?
|
| Anus Neoplasms | 1 | 2014 | 329 | 0.090 |
Why?
|
| Radiotherapy, Computer-Assisted | 2 | 2008 | 90 | 0.090 |
Why?
|
| Lung Neoplasms | 8 | 2010 | 13380 | 0.090 |
Why?
|
| Respiratory-Gated Imaging Techniques | 1 | 2010 | 75 | 0.080 |
Why?
|
| Vagina | 1 | 2014 | 838 | 0.080 |
Why?
|
| Monte Carlo Method | 2 | 2010 | 1258 | 0.070 |
Why?
|
| Liver | 2 | 2020 | 7529 | 0.070 |
Why?
|
| Phantoms, Imaging | 3 | 2010 | 2526 | 0.070 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 58976 | 0.060 |
Why?
|
| Quality Control | 1 | 2008 | 832 | 0.060 |
Why?
|
| Ependymoma | 1 | 2008 | 320 | 0.060 |
Why?
|
| Lymphatic Metastasis | 3 | 2009 | 2915 | 0.060 |
Why?
|
| Prognosis | 7 | 2020 | 29625 | 0.060 |
Why?
|
| Contrast Media | 2 | 2015 | 5311 | 0.060 |
Why?
|
| Extremities | 1 | 2009 | 867 | 0.060 |
Why?
|
| Heart | 2 | 2014 | 4404 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 39106 | 0.050 |
Why?
|
| Aged | 18 | 2020 | 169289 | 0.050 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 1222 | 0.050 |
Why?
|
| Patient Selection | 1 | 2014 | 4244 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2018 | 4652 | 0.050 |
Why?
|
| Treatment Failure | 3 | 2017 | 2645 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2017 | 882 | 0.050 |
Why?
|
| Artifacts | 1 | 2010 | 1911 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 5368 | 0.050 |
Why?
|
| Particle Accelerators | 1 | 2021 | 174 | 0.050 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2009 | 1159 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10194 | 0.040 |
Why?
|
| Radiometry | 2 | 2020 | 813 | 0.040 |
Why?
|
| Middle Aged | 16 | 2020 | 220895 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2010 | 4063 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 1654 | 0.040 |
Why?
|
| Humans | 30 | 2023 | 761504 | 0.040 |
Why?
|
| Sarcoma | 1 | 2009 | 1801 | 0.040 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2018 | 50 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2009 | 1959 | 0.040 |
Why?
|
| Survival Rate | 3 | 2018 | 12725 | 0.040 |
Why?
|
| Protons | 1 | 2023 | 1116 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2018 | 310 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2018 | 306 | 0.030 |
Why?
|
| Female | 18 | 2020 | 392644 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5247 | 0.030 |
Why?
|
| Cholelithiasis | 1 | 2017 | 407 | 0.030 |
Why?
|
| Male | 15 | 2020 | 360804 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 36426 | 0.030 |
Why?
|
| Retrospective Studies | 7 | 2020 | 80636 | 0.030 |
Why?
|
| Adult | 10 | 2020 | 221177 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 1379 | 0.030 |
Why?
|
| Organs at Risk | 1 | 2014 | 359 | 0.030 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2013 | 296 | 0.030 |
Why?
|
| Radiation Tolerance | 1 | 2014 | 479 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2007 | 5315 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2017 | 54425 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6228 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 11121 | 0.020 |
Why?
|
| Models, Biological | 2 | 2018 | 9469 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2017 | 1958 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2018 | 2200 | 0.020 |
Why?
|
| Radiography | 2 | 2009 | 6965 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2009 | 348 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2009 | 318 | 0.020 |
Why?
|
| Time Factors | 3 | 2018 | 39967 | 0.020 |
Why?
|
| Dextrans | 1 | 2009 | 574 | 0.020 |
Why?
|
| Carcinoma, Large Cell | 1 | 2007 | 113 | 0.020 |
Why?
|
| Exhalation | 1 | 2007 | 181 | 0.020 |
Why?
|
| Thorax | 1 | 2010 | 555 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 9031 | 0.020 |
Why?
|
| Mediastinum | 1 | 2007 | 267 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2018 | 64680 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4369 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2010 | 876 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 818 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 22170 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2009 | 21012 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14666 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4580 | 0.010 |
Why?
|
| Water | 1 | 2009 | 1411 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2014 | 3096 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2005 | 11118 | 0.010 |
Why?
|
| Genotype | 1 | 2017 | 12990 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2014 | 3807 | 0.010 |
Why?
|
| Motion | 1 | 2006 | 779 | 0.010 |
Why?
|
| Reference Values | 1 | 2009 | 4920 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 20098 | 0.010 |
Why?
|
| Pelvis | 1 | 2005 | 732 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2008 | 1271 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2009 | 2242 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13506 | 0.010 |
Why?
|
| Lung | 2 | 2010 | 10000 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13255 | 0.010 |
Why?
|
| Young Adult | 2 | 2014 | 59243 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 3357 | 0.010 |
Why?
|
| Risk Factors | 1 | 2022 | 74206 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 4026 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 30052 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2006 | 6240 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 41487 | 0.010 |
Why?
|
| Software | 1 | 2006 | 4434 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 6346 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14031 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 22176 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2009 | 15631 | 0.000 |
Why?
|
| Infant | 1 | 2008 | 36192 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2008 | 42230 | 0.000 |
Why?
|
| Adolescent | 1 | 2009 | 88319 | 0.000 |
Why?
|
| Child | 1 | 2008 | 80153 | 0.000 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_